论文信息 - Prognostic Indicators in Chemotherapy for Head and Neck Carcinoma: Alkaline Phosphatase Levels

Prognostic Indicators in Chemotherapy for Head and Neck Carcinoma: Alkaline Phosphatase Levels

Serum alkaline phosphatase (AP), total bilirubin, total protein, serum albumin, and serum glutamic oxaloacetic transaminase (SGOT) were determined in 55 patients with biopsy proven carcinoma of the head and neck prior to their induction chemotherapy with cis‐platlnum and bleomycin. Of the 55 patients, 40 (73%) exhibited either a complete or partial response (tumor mass decreased by over 50%) to the chemotherapy.

[1] R. Hurt,et al. Screening for alcoholism. , 1979, JAMA.

[2] H. Muss,et al. Serum alkaline phosphatase determination. Value in the staging of advanced breast cancer. , 1979, JAMA.

[3] T. F. Patton,et al. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II). , 1979, Cancer treatment reports.

[4] S. Shapshay,et al. Induction chemotherapy in advanced squamous head and neck carcinoma with high‐dose cis‐platinum and bleomycin infusion , 1979, Cancer.

[5] L. Sternson,et al. Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma. , 1977, Clinical chemistry.

[6] R. Golbey,et al. High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis , 1977, Cancer.

[7] R. Lange,et al. Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). , 1973, Cancer research.

[8] M. Kaplan. Alkaline phosphatase. , 1972, Gastroenterology.